# Topical Ruxolitinib Evaluation in Chronic Hand Eczema

> **NCT05906628** · PHASE2 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 186 (actual)

## Conditions studied

- Hand Eczema

## Interventions

- **DRUG:** Ruxolitinib cream
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05906628
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-31
- **Primary completion:** 2024-07-15
- **Final completion:** 2024-12-13
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05906628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05906628, "Topical Ruxolitinib Evaluation in Chronic Hand Eczema". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05906628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*